Alpha Tau Medical Ltd.DRTS stock score: 30/100
$11.31 · -5.83% · Scored Nov 19, 2026
- Technical
- 47
- Fundamental
- 26
- News
- 58
The reading
Alpha Tau Medical (DRTS) scores 30 out of 100, which reads bearish, higher than 4% of Healthcare stocks and 6% of the 4,118 US stocks we score.
The composite weights fundamentals 80% and technicals 20%: fundamentals read 26, technicals 47.
Among the fundamentals, Quick Ratio at 100 and Price Target at 100 score highest, while Earnings Quality (Quarterly) at 0 weighs the most against it.
On the daily chart, trend-following indicators average 27 and contrarian oscillators 70 — a split worth reading before trusting the technical total.
News sentiment is neutral at 58; it is shown, not counted in the composite.
Since Aug 23, 2026 the composite has ranged from 30 to 48, and it is down 18 points over the period.
About Alpha Tau Medical
Alpha Tau Medical (DRTS) is an Israel-based medical device company developing Alpha DaRT, a cancer treatment that delivers alpha radiation directly inside solid tumors. Small radioactive sources implanted in the tumor release atoms that diffuse a short distance and emit alpha particles meant to destroy cancer cells while limiting harm to healthy tissue. Alpha DaRT is approved for commercial use in Israel, and the company is pursuing FDA approval for recurrent cutaneous squamous cell carcinoma, an indication that holds Breakthrough Device Designation. Clinical programs cover pancreatic cancer, recurrent glioblastoma and skin cancer in immunocompromised patients. The company has a collaboration with Tolmar to develop and commercialize Alpha DaRT for prostate cancer in the United States. Alpha Tau has little product revenue and funds its work mainly through capital raises and partnership payments.
Alpha DaRT competes with established cancer treatments, including external beam radiation, conventional brachytherapy, surgery and drug therapies, and with other developers of targeted alpha therapies. Its edge rests on an approach that places alpha emitters inside the tumor and on clinical data gathered across several tumor types. Investors who follow DRTS stock tend to watch regulatory decisions in the United States and Japan and data from the pancreatic, brain and skin cancer trials. Progress under the Tolmar collaboration is closely followed. Cash runway and manufacturing scale-up are other factors.
What’s driving the score
The strongest and weakest of the scorers that count toward DRTS’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.
Fundamental
26Pulling it up
- Quick Ratio100
Quick ratio measures a company's ability to meet short-term obligations with liquid assets.
- Price Target100
Price target score compares the current stock price to analyst consensus targets.
Current assets divided by current liabilities: the ability to pay short-term bills.
Holding it back
How often the company beat analysts' EPS estimates over recent quarters, by how much, and the trend in reported EPS from quarter to quarter.
How reliably yearly earnings grow: the share of years with higher earnings, the compound growth rate, how steady that growth is, and the last two yearly changes.
Return on Equity (ROE) measures how efficiently a company generates profits from shareholder equity.
26 weighted scorers; 13 had no data today and are left out rather than counted as zero.
Technical · daily
35Pulling it up
Bollinger Bands (20-period) plot standard deviations above and below a moving average.
Bollinger Bands (50-period) measure where price sits between bands two standard deviations around its 50-period average.
The price change over the last 52 weeks.
Holding it back
Ichimoku Cloud is a comprehensive indicator showing support/resistance, trend direction, and momentum.
Simple Moving Average (10-period) smooths price action over 10 periods.
- VWAP0
Volume Weighted Average Price (VWAP) shows the average price weighted by volume.
62 weighted scorers; 3 had no data today and are left out rather than counted as zero.
News · shown, not counted
- Global News
- 58
Technical score by timeframe
| Chart | Score | Weight |
|---|---|---|
| Hourly | 32 | 1 |
| Daily | 35 | 3 |
| Weekly | 53 | 2 |
| Monthly | 67 | 2 |
Composite score, last 90 days
Show the daily numbers
| Date | Composite |
|---|---|
| Nov 19, 2026 | 30 |
| Nov 18, 2026 | 31 |
| Nov 17, 2026 | 31 |
| Nov 16, 2026 | 32 |
| Nov 15, 2026 | 33 |
| Nov 14, 2026 | 34 |
| Nov 13, 2026 | 34 |
| Nov 12, 2026 | 32 |
| Nov 11, 2026 | 47 |
| Nov 10, 2026 | 44 |
| Nov 7, 2026 | 45 |
| Nov 6, 2026 | 45 |
| Nov 5, 2026 | 43 |
| Nov 4, 2026 | 47 |
| Nov 3, 2026 | 45 |
| Nov 2, 2026 | 42 |
| Nov 1, 2026 | 42 |
| Oct 30, 2026 | 42 |
| Oct 29, 2026 | 44 |
| Oct 28, 2026 | 44 |
| Oct 27, 2026 | 44 |
| Oct 26, 2026 | 42 |
| Oct 25, 2026 | 43 |
| Oct 24, 2026 | 43 |
| Oct 23, 2026 | 43 |
| Oct 22, 2026 | 41 |
| Oct 21, 2026 | 45 |
| Oct 20, 2026 | 42 |
| Oct 19, 2026 | 41 |
| Oct 18, 2026 | 41 |
| Oct 17, 2026 | 41 |
| Oct 16, 2026 | 40 |
| Oct 15, 2026 | 42 |
| Oct 14, 2026 | 43 |
| Oct 13, 2026 | 43 |
| Oct 12, 2026 | 45 |
| Oct 11, 2026 | 45 |
| Oct 10, 2026 | 45 |
| Oct 9, 2026 | 45 |
| Oct 8, 2026 | 43 |
| Oct 7, 2026 | 44 |
| Oct 6, 2026 | 46 |
| Oct 5, 2026 | 46 |
| Oct 4, 2026 | 45 |
| Oct 3, 2026 | 45 |
| Oct 2, 2026 | 45 |
| Oct 1, 2026 | 44 |
| Sep 30, 2026 | 46 |
| Sep 29, 2026 | 48 |
| Sep 28, 2026 | 47 |
| Sep 27, 2026 | 46 |
| Sep 26, 2026 | 46 |
| Sep 25, 2026 | 45 |
| Sep 24, 2026 | 46 |
| Sep 23, 2026 | 47 |
| Sep 22, 2026 | 46 |
| Sep 21, 2026 | 48 |
| Sep 20, 2026 | 47 |
| Sep 19, 2026 | 47 |
| Sep 18, 2026 | 47 |
| Sep 17, 2026 | 48 |
| Sep 16, 2026 | 47 |
| Sep 15, 2026 | 47 |
| Sep 14, 2026 | 45 |
| Sep 13, 2026 | 46 |
| Sep 12, 2026 | 46 |
| Sep 11, 2026 | 46 |
| Sep 10, 2026 | 46 |
| Sep 9, 2026 | 45 |
| Sep 8, 2026 | 48 |
| Sep 7, 2026 | 48 |
| Sep 6, 2026 | 48 |
| Sep 5, 2026 | 48 |
| Sep 4, 2026 | 47 |
| Sep 2, 2026 | 47 |
| Sep 1, 2026 | 46 |
| Aug 31, 2026 | 45 |
| Aug 30, 2026 | 47 |
| Aug 29, 2026 | 47 |
| Aug 28, 2026 | 46 |
| Aug 27, 2026 | 48 |
| Aug 26, 2026 | 48 |
| Aug 25, 2026 | 47 |
| Aug 24, 2026 | 48 |
| Aug 23, 2026 | 48 |
Key facts
- Market cap
- $1.0B
- Sector
- Healthcare
- Industry
- Biotechnology
- Beta
- 1.29
- Risk grade (1–10)
- —
- Next earnings
- Nov 19, 2026
Biotechnology peers
| Company | Market cap | Score |
|---|---|---|
| VOR Vor Biopharma | $1.1B | 43 |
| NKTR Nektar Therapeutics | $1.1B | 27 |
| INBX Inhibrx Biosciences | $1.1B | 38 |
| ANRO Alto Neuroscience | $1.1B | 36 |
| OMER Omeros | $1.0B | 57 |
| JBIO Jade Biosciences | $1.0B | 36 |
Questions
What is DRTS's stock rating today?
DRTS scores 30/100 (Bearish) as of Nov 19, 2026: technical 47, fundamental 26, and news sentiment 58, which is shown but not counted. Scores are recomputed every night.
What does Alpha Tau Medical do?
Alpha Tau Medical (DRTS) is an Israel-based medical device company developing Alpha DaRT, a cancer treatment that delivers alpha radiation directly inside solid tumors. Small radioactive sources implanted in the tumor release atoms that diffuse a short distance and emit alpha particles meant to destroy cancer cells while limiting harm to healthy tissue.
Is DRTS stock a buy?
The score is not a buy or sell recommendation. A 30 says the technical and fundamental signals we measure lean bearish today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.
How is the DRTS score calculated?
88 weighted scorers feed it today: 26 fundamental, scored against Healthcare ranges, and 62 technical on the daily chart, with 4 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.
Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.
Embed this score
A badge for a blog post, newsletter or README. It updates every night and links back here. More badges
HTML
<a href="https://stocksscores.com/stocks/drts/"><img src="https://stocksscores.com/stocks/drts/badge.svg" alt="DRTS stock score" height="20"></a>
Markdown
[](https://stocksscores.com/stocks/drts/)